U.S. Biotech Stock News

Equifax (EFX) recently reported Q4 2025 results that surpassed analyst expectations on both EPS and revenue, and that stronger quarter has coincided with a more positive stance from analysts on the stock. See our latest analysis for Equifax. The stronger Q4 report and launch of the new myEquifax consumer app have come after a tougher stretch for shareholders, with a 30 day share price return of 11.65% and a 90 day share price return of 14.78%. At the same time, the 1 year total shareholder...

In March 2026, PROCEPT BioRobotics announced that the European Association of Urology updated its guidelines to give Aquablation therapy a strong recommendation as a surgical option for men with benign prostatic hyperplasia, particularly those seeking to preserve ejaculatory function. This upgrade, grounded in a large body of randomized and long-term clinical evidence and aligned with support from bodies such as NICE in the UK, further embeds Aquablation within mainstream urologic practice...

Pomerantz LLP has launched an investigation into Weis Markets, Inc. after the retailer disclosed in the past that it would restate certain financial statements due to inaccurately recorded and overstated inventory, and delay filing its 2025 Annual Report while the review is completed. The combination of a restatement tied to inventory overstatement and an external securities-law investigation raises deeper questions about Weis Markets’ internal controls, governance, and financial reporting...

United States Antimony Corporation recently restarted mining operations at its Montana properties following a winter shutdown, introduced GPS-based vein mapping and mulch-based reclamation practices, and expanded its portfolio with new antimony-focused mining claims in Alaska, Montana, and Ontario. These operational changes and resource acquisitions could meaningfully influence how investors assess the company’s production potential, asset base, and long-term operating profile. We’ll now...

Cellebrite DI’s Spring 2026 Release, announced in March 2026, expanded lawful access across the latest iOS and Android devices, introduced Safeguard Mode for time-sensitive data capture, added drone forensics capabilities, and brought Corellium virtualized testing to Google Cloud in public preview. By pairing next-generation digital forensics, including drone data extraction, with cloud-based Corellium for virtual Arm system testing, Cellebrite is pushing deeper into both public-sector...

Dutch Bros Coffee has continued its rapid physical expansion in recent weeks, opening and planning new drive-thru locations across markets including Baton Rouge, the Midlands, St. Joseph, Daytona Beach, Nampa, Titusville and Champaign, while also advancing into new territories such as Lynchburg pending approvals. Alongside this footprint growth, the company reported quarterly earnings that exceeded analyst expectations and launched brand-building initiatives like a March Madness NIL...

Over the past week, Nucor has attracted fresh attention as banks including Goldman Sachs and KeyBanc began coverage while management indicated first-quarter earnings should rise across all segments, led by its steel mills, alongside US$250 million returned to shareholders through dividends and buybacks in the first quarter. With analysts now expecting a very large year-over-year earnings jump into the forthcoming April 27 results release and issuing broadly positive ratings, the market is...

Surgery Partners (SGRY) is back in focus after reporting softer quarterly results, characterized by weak sales volumes, slower projected revenue growth, and high debt levels that increase financial risk and keep investor sentiment cautious. See our latest analysis for Surgery Partners. The share price slump has been sharp, with a 12.5% 30 day share price return and a 20.2% year to date share price return contributing to a 46.6% 1 year total shareholder return, which points to fading momentum...

InterDigital, Inc. recently secured a preliminary injunction in Brazil against Transsion over alleged 5G patent infringement and announced new patent license agreements with Buffalo Americas, Inc. for Wi‑Fi 5 and Wi‑Fi 6, along with fresh deals with a global TV manufacturer. Together, these legal and licensing developments underscore InterDigital’s ability to both enforce and commercialize its wireless intellectual property across smartphones, networking gear, and consumer electronics. We’ll...

On March 23, 2026, First Industrial Realty Trust, Inc. reported that activist investor Land & Buildings withdrew its director nominee ahead of the April 30, 2026 annual meeting, while the Board authorized a US$250 million share repurchase and announced the addition of new independent director Frank E. Schmitz effective June 1, 2026. This resolution of the proxy dispute, paired with a sizable buyback authorization, underscores management’s focus on governance stability and capital returns for...

ORIC Pharmaceuticals recently reported detailed Phase 1b dose-optimization data for rinzimetostat in metastatic castration-resistant prostate cancer and, based on an 84% 5‑month radiographic progression-free survival and favorable tolerability at 400 mg once daily with darolutamide, selected this regimen as the recommended Phase 3 dose for the planned global Himalayas-1 registrational trial starting in the first half of 2026. Beyond the headline efficacy, the company’s extensive...

In March 2026, AnaptysBio announced plans to spin off First Tracks Biotherapeutics, manage existing drug collaborations with GSK and Vanda, operate with limited staff and expenses, and start with about US$140 million to US$145 million in net cash and investments, while also launching a US$100 million share repurchase program and withdrawing a US$100 million at-the-market equity offering. The combination of a buyback authorization, canceled equity raise, and the addition of seasoned...

Recent performance snapshot Tractor Supply (TSCO) has drawn attention after a one-month return of about a 15% decline and a past three-month return of about a 14% decline, putting its recent performance in sharper focus for investors. See our latest analysis for Tractor Supply. The recent 30 day share price return of around a 15% decline and year to date share price return of about a 14% decline suggest momentum has been fading, even though the 5 year total shareholder return of roughly 35%...

Westlake (WLK) is back in focus after an earnings miss that contrasted with a wave of analyst upgrades, with sentiment supported by signs of polyethylene cycle acceleration and tighter supply from temporary global shutdowns. See our latest analysis for Westlake. That bullish backdrop has been reflected in the price action, with a 61.02% year to date share price return and a 30.13% 1 year total shareholder return. This suggests momentum has been building despite the recent earnings miss. If...

Fresh Del Monte Produce (FDP) is back on investors’ radar after reporting quarterly revenue of US$1.02b, flat year on year, while exceeding expectations on earnings and gross margin. This prompted a 3.7% post-earnings share price gain. See our latest analysis for Fresh Del Monte Produce. The earnings beat comes on top of a 16.8% 90 day share price return and a 35.7% 1 year total shareholder return. Together, these figures suggest improving sentiment after a softer recent 30 day share price...

Edison International recently announced it will hold a conference call on April 28, 2026, to discuss its first quarter financial results, alongside reporting reduced short interest and issuing earnings guidance for 2026 and 2027 that exceeded analyst expectations. At the same time, Edison International’s backing of ThinkLabs AI’s US$28.00 million Series A round underscores its push toward AI-native grid planning and operational efficiency tools, aligning with broader efforts to modernize the...

In late March 2026, Fifth Third Bancorp completed its acquisition of Comerica Inc. and saw regional bank shares rally as geopolitical tensions with Iran eased, improving sentiment toward the financial sector. Analysts now highlight the Comerica deal as a key source of potential cost efficiencies and loan growth for Fifth Third, while institutional investors’ contrasting moves underscore how differently market participants are interpreting the bank’s post-merger outlook. We’ll now examine how...

Event driven interest in GE Vernova stock GE Vernova (GEV) is back in focus after a series of contract wins, index inclusion and trading signals that point to rising investor attention despite recent bouts of geopolitical driven volatility. See our latest analysis for GE Vernova. After a sharp run that has taken the share price to US$898.57, GE Vernova’s recent 6.72% 1 month share price return and 32.23% year to date share price return, alongside a 1 year total shareholder return of 202.77%,...

Lucid Group (LCID) is back in focus after unveiling its updated 2027 Gravity SUV lineup. The company is pairing richer standard features and a new Prestige Package with recent commentary on margin goals and broader market reach. See our latest analysis for Lucid Group. The Gravity news lands at a time when Lucid’s 1 day share price return of 4.18% contrasts with a year to date share price return of negative 10.67% and a 1 year total shareholder return of negative 57.07%. This points to short...

In March 2026, large shareholders including OEP VII GP, L.L.C. and ONE EQUITY PARTNERS purchased nearly US$24.3 million of AdaptHealth common stock following its mixed Q4 2025 results, where earnings per share missed expectations but revenue slightly exceeded forecasts. The scale and timing of these insider and institutional purchases, occurring soon after the earnings release, suggest that key long-term holders viewed the post-result setup as attractive despite recent profitability...

Ocular Therapeutix (OCUL) is drawing fresh attention as investors look ahead to upcoming April conferences, where the company plans to share additional analyses from its pivotal Phase 3 SOL-1 trial of AXPAXLI. See our latest analysis for Ocular Therapeutix. At a share price of US$8.49, Ocular Therapeutix has seen a 1-day share price return of 1.92% and 7-day share price return of 5.20%. The 30-day share price return of 21.10% and year to date share price return of 28.17% are being considered...

Annaly Capital Management (NLY) drew fresh attention after investor Bill Ackman publicly called mortgage finance names “stupidly cheap” and outlined what he views as a highly skewed risk reward, sparking a 1.9% intraday share move. See our latest analysis for Annaly Capital Management. At a share price of $21.37, Annaly’s 1 day share price return of 1.14% and 7 day share price return of 1.47% sit against a 30 day share price return of a 7.25% decline. Its 1 year total shareholder return of...

In recent days, AppFolio’s shares have moved on growing attention to its upcoming earnings release, where analysts expect year-over-year increases in both earnings and revenue. This anticipation is reinforced by AppFolio’s current Zacks Rank of #2 (Buy), signaling relatively strong analyst confidence despite a premium valuation. With analysts projecting earnings of $1.44 per share for the upcoming report, we’ll examine how this shapes AppFolio’s broader investment narrative. Rare earth...

Marsh & McLennan Companies (MRSH) is back in focus after the firm promoted Ted Moynihan to president and CEO of Marsh Management Consulting and Oliver Wyman, continuing a broader reshuffle across its senior leadership. See our latest analysis for Marsh & McLennan Companies. The share price has softened recently, with a 30 day share price return of 5.22% and a year to date share price return decline of 4.31%. However, the 5 year total shareholder return of 50.16% points to a much stronger...